(Q37101296)

18 August 2017

1 reference

title

Switching algorithms: from one immunomodulatory agent to another (English)

1 reference

18 August 2017

0 references

Patricia K Coyle

1

1 reference

18 August 2017

1 March 2008

1 reference

18 August 2017

1 reference

18 August 2017

255 Suppl 1

1 reference

18 August 2017

44-50

1 reference

https://scigraph.springernature.com/pub.10.1007/s00415-008-1007-3

18 August 2017

0 references

cites work

Identifying and treating patients with suboptimal responses

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00415-008-1007-3

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00415-008-1007-3

21 January 2018

1 reference

12 December 2020

Randomized controlled trial of interferon-beta-1a in secondary progressive MS: MRI results

1 reference

12 December 2020

Guidelines on use of anti-IFN-beta antibody measurements in multiple sclerosis: report of an EFNS Task Force on IFN-beta antibodies in multiple sclerosis

1 reference

12 December 2020

Randomized, double-blind, dose-comparison study of glatiramer acetate in relapsing-remitting MS.

1 reference

12 December 2020

Glatiramer acetate in primary progressive multiple sclerosis: results of a multinational, multicenter, double-blind, placebo-controlled trial

1 reference

12 December 2020

Defining the response to interferon-β in relapsing-remitting multiple sclerosis patients

1 reference

12 December 2020

Post-marketing survey on clinical response to interferon beta in relapsing multiple sclerosis: the Roman experience

1 reference

12 December 2020

Glatiramer acetate in treatment-naïve and prior interferon-beta-1b-treated multiple sclerosis patients.

1 reference

12 December 2020

The efficacy of glatiramer acetate in beta-interferon-intolerant MS patients

1 reference

12 December 2020

Neutralising antibodies to interferon beta in multiple sclerosis : expert panel report

1 reference

12 December 2020

Neutralizing antibodies to interferon beta: assessment of their clinical and radiographic impact: an evidence report: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

1 reference

12 December 2020

Clinical course after change of immunomodulating therapy in relapsing-remitting multiple sclerosis

1 reference

12 December 2020

10.1007/S00415-008-1007-3

Identifiers

DOI

1 reference

18 August 2017

1 reference

PubMed ID

18317676